JUN 09, 2016 2:52 PM PDT

Making Bone Marrow Transplants Safer with Antibodies

WRITTEN BY: Xuan Pham

For some patients, bone marrow transplants are one of the few last defenses that could save their lives. But this procedure is extremely dangerous and prone to side-effects that could last a lifetime. Now researchers at the Harvard Medical School have developed a new way to transplant bone marrow that’s safer and more effective. Their work, though only done in mice, give hope that the technology could one day be applied safely to millions of people who are in desperate need of the life-saving procedure.

David Scadden and Rahul PalchaudhuriA bone marrow transplant is a procedure that replaces a patient’s diseased blood stem cells with healthy ones from a matched donor. There are several conditions that warrant a bone marrow transplant. These often involve blood disorders, such as cancer of the blood (leukemia), sickle cell anemia, or thalassemia. In some instances, chemotherapy or radiation treatment can damage the bone marrow, necessitating a transplant.

Before doctors can transplant healthy donor cells into a recipient patient, they must first wipe out the diseased blood cells from the patient’s bone marrow. This requires extremely toxic treatments that increase the risk for complications such as bleeding, infection, and organ damage. As such, finding a safer way to deliver this procedure is critical.

In order to get rid of diseased blood cells safely, researchers at Harvard turned to antibodies, which are inherently specific to their targets. "Instead of using non-targeted drugs that have lots of collateral damage we thought we could take advantage of the precision of the immune system, in particular, antibodies," said David Scadden, Professor of Medicine at Harvard University, and senior study author.

The team armed antibodies with a killing payload that’s specific to a blood marker known as CD45. "Antibodies are remarkably specific in what they target," said Rahul Palchaudhuri, the study’s first author. "We can direct them to CD45, a cell marker which is exclusively expressed in the blood system. That way we avoid toxicities to non-blood tissues."
 

 


In this approach, the antibodies can’t harm the thymus and bone marrow environments, which are crucial nurseries for T cells and innate immune cells. As a result, the body can still defend itself against infections that would otherwise be dangerously fatal if these cells were destroyed.

They tested their procedure in mice, and showed that mice with antibody treatment withstood infection better than mice treated with standard radiation. Antibody treatment also enabled mice to accept a bone marrow transplant, and be cured of their sickle cell anemia condition.

Interestingly, the team reported no severe adverse effects in mice given the antibody treatment, even if transplants didn’t follow. This means that the procedure won’t confine patients to a long, sterile hospital bed while they recover, and that a failed transplant won’t be fatal. But the caveat is that these results have only been observed in animal studies.

"If this approach works in humans, it will really change the conversation that providers have with patients," Scadden said. The procedure would open transplant possibilities especially for those "who have these underlying genetic disorders and for who the new gene-editing and gene therapy techniques are being developed."

Additional sources: Science Daily

Image credit: BD Bolen & Harvard Medical School

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 29, 2021
Clinical & Molecular DX
Can We Diagnose Disease Based on How "Sticky" Cells Are?
APR 29, 2021
Can We Diagnose Disease Based on How "Sticky" Cells Are?
How “sticky” cells are, or their viscosity, holds a wealth of information about their health and functionali ...
APR 27, 2021
Clinical & Molecular DX
No Batteries: Health Sensor Harvests Biomechanical Energy
APR 27, 2021
No Batteries: Health Sensor Harvests Biomechanical Energy
An international team of researchers has developed a wearable health monitor that works without the need for batteries. ...
MAY 24, 2021
Clinical & Molecular DX
Discovery of Viral Peptides Paves the Way for Cheaper, More Accurate COVID Diagnostics
MAY 24, 2021
Discovery of Viral Peptides Paves the Way for Cheaper, More Accurate COVID Diagnostics
Over 1.5 billion vaccine doses have been administered worldwide, but SARS-CoV-2 variants are now threatening efforts to ...
JUN 09, 2021
Clinical & Molecular DX
Faster, Cheaper Diagnosis of Rare Cancer in Fat Cells
JUN 09, 2021
Faster, Cheaper Diagnosis of Rare Cancer in Fat Cells
Scientists have created a gene panel test to quickly and more precisely diagnose common forms of liposarcoma. This break ...
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUL 06, 2021
Clinical & Molecular DX
Undiagnosed Dementia Much More Prevalent Than Previously Thought
JUL 06, 2021
Undiagnosed Dementia Much More Prevalent Than Previously Thought
An analysis of data from the Health and Retirement Study has yielded a startling revelation: 91 percent of people experi ...
Loading Comments...